BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15324309)

  • 1. Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition.
    Chaplet M; Detry C; Deroanne C; Fisher LW; Castronovo V; Bellahcéne A
    Biochem J; 2004 Dec; 384(Pt 3):591-8. PubMed ID: 15324309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions.
    Okamoto S; Jiang Y; Kawamura K; Shingyoji M; Tada Y; Sekine I; Takiguchi Y; Tatsumi K; Kobayashi H; Shimada H; Hiroshima K; Tagawa M
    Cell Death Dis; 2014 Nov; 5(11):e1517. PubMed ID: 25393473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells.
    Mikami Y; Omoteyama K; Kato S; Takagi M
    Biochem Biophys Res Commun; 2007 Oct; 362(2):368-73. PubMed ID: 17707772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro.
    Pan B; To LB; Farrugia AN; Findlay DM; Green J; Gronthos S; Evdokiou A; Lynch K; Atkins GJ; Zannettino AC
    Bone; 2004 Jan; 34(1):112-23. PubMed ID: 14751568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid regulation of bone sialoprotein (BSP) gene expression. Identification of a glucocorticoid response element in the bone sialoprotein gene promoter.
    Ogata Y; Yamauchi M; Kim RH; Li JJ; Freedman LP; Sodek J
    Eur J Biochem; 1995 May; 230(1):183-92. PubMed ID: 7601099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human bone sialoprotein gene transcription by platelet-derived growth factor-BB.
    Mezawa M; Araki S; Takai H; Sasaki Y; Wang S; Li X; Kim DS; Nakayama Y; Ogata Y
    Gene; 2009 Apr; 435(1-2):80-7. PubMed ID: 19393184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.
    Viereck V; Emons G; Lauck V; Frosch KH; Blaschke S; Gründker C; Hofbauer LC
    Biochem Biophys Res Commun; 2002 Mar; 291(3):680-6. PubMed ID: 11855844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Runx2- and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression.
    Lamour V; Detry C; Sanchez C; Henrotin Y; Castronovo V; Bellahcène A
    J Biol Chem; 2007 Dec; 282(50):36240-9. PubMed ID: 17956871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates modulate vital functions of human osteoblasts and affect their interactions with breast cancer cells.
    Kaiser T; Teufel I; Geiger K; Vater Y; Aicher WK; Klein G; Fehm T
    Breast Cancer Res Treat; 2013 Jul; 140(1):35-48. PubMed ID: 23807419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE).
    Pan B; Farrugia AN; To LB; Findlay DM; Green J; Lynch K; Zannettino AC
    J Bone Miner Res; 2004 Jan; 19(1):147-54. PubMed ID: 14753746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts.
    Id Boufker H; Lagneaux L; Fayyad-Kazan H; Badran B; Najar M; Wiedig M; Ghanem G; Laurent G; Body JJ; Journé F
    Bone; 2011 Dec; 49(6):1219-31. PubMed ID: 21893226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of bone sialoprotein gene transcription by steroid hormones.
    Sodek J; Kim RH; Ogata Y; Li J; Yamauchi M; Zhang Q; Freedman LP
    Connect Tissue Res; 1995; 32(1-4):209-17. PubMed ID: 7554919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells.
    Goffinet M; Thoulouzan M; Pradines A; Lajoie-Mazenc I; Weinbaum C; Faye JC; Séronie-Vivien S
    BMC Cancer; 2006 Mar; 6():60. PubMed ID: 16539721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I increases bone sialoprotein (BSP) expression through fibroblast growth factor-2 response element and homeodomain protein-binding site in the proximal promoter of the BSP gene.
    Nakayama Y; Nakajima Y; Kato N; Takai H; Kim DS; Arai M; Mezawa M; Araki S; Sodek J; Ogata Y
    J Cell Physiol; 2006 Aug; 208(2):326-35. PubMed ID: 16642470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Static magnetic fields-induced bone sialoprotein (BSP) expression is mediated through FGF2 response element and pituitary-specific transcription factor-1 motif.
    Shimizu E; Matsuda-Honjyo Y; Samoto H; Saito R; Nakajima Y; Nakayama Y; Kato N; Yamazaki M; Ogata Y
    J Cell Biochem; 2004 Apr; 91(6):1183-96. PubMed ID: 15048873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone sialoprotein gene transfer to periodontal ligament cells may not be sufficient to promote mineralization in vitro or in vivo.
    Hakki SS; Wang D; Franceschi RT; Somerman MJ
    J Periodontol; 2006 Feb; 77(2):167-73. PubMed ID: 16460240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates hinder osteoblastic/osteoclastic differentiation in the maxillary sinus mucosa-derived stem cells.
    Zhang J; Park J; Lee JW; Kwon YD; Kim EC
    Clin Oral Investig; 2018 Jun; 22(5):1933-1943. PubMed ID: 29188452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoledronate has an antitumor effect and induces actin rearrangement in dexamethasone-resistant myeloma cells.
    Koizumi M; Nakaseko C; Ohwada C; Takeuchi M; Ozawa S; Shimizu N; Cho R; Nishimura M; Saito Y
    Eur J Haematol; 2007 Nov; 79(5):382-91. PubMed ID: 17903213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaempferol stimulates bone sialoprotein gene transcription and new bone formation.
    Yang L; Takai H; Utsunomiya T; Li X; Li Z; Wang Z; Wang S; Sasaki Y; Yamamoto H; Ogata Y
    J Cell Biochem; 2010 Aug; 110(6):1342-55. PubMed ID: 20564228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of FGF2-response element in the rat bone sialoprotein gene promoter.
    Shimizu-Sasaki E; Yamazaki M; Furuyama S; Sugiya H; Sodek J; Ogata Y
    Connect Tissue Res; 2003; 44 Suppl 1():103-8. PubMed ID: 12952182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.